Laura Lovett

How doctors are using the Apple Watch to ease transcription woes
By Laura Lovett | 03:45 pm | September 16, 2020
Notable's voice-powered assistant was developed to help curb the time doctors spend on charting. 
Capsule Technologies earns FDA green light on capnography monitor
By Laura Lovett | 03:49 pm | September 15, 2020
The new tool can monitor a patient's end-tidal carbon dioxide, respiratory rate, and fractional inspired CO2.
London virtual care company Medefer scores £10M to grow its business
By Laura Lovett | 03:29 pm | September 15, 2020
The company offers virtual care visits, virtual outpatient pathways and a tech platform for doctors to conduct virtual visits. 
NVIDIA looks to telehealth with automatic speech recognition tool
By Laura Lovett | 03:40 pm | September 14, 2020
After a telemedicine visit, a patient or provider can look at the transcription and notes. 
Seniors have the potential to transform economy and the healthcare system
By Laura Lovett | 09:45 am | September 11, 2020
At HIMSS & Health 2.0 Europe Digital Event 2020, panelists talk about retired individuals' role in the healthcare ecosystem and healthy ageing. 
Femtech's sexual health revolution
By Laura Lovett | 11:52 am | September 10, 2020
Panelists at the HIMSS & Health 2.0 European Digital Conference discuss how digital health can help women learn more about their sexual health and wellbeing. 
Veteran clinical navigation platform Grand Rounds raises $175M
By Laura Lovett | 03:01 pm | September 09, 2020
Truepill scores $75M in Series C funding and looks to roll out at-home testing services
By Laura Lovett | 02:11 pm | September 09, 2020
This news comes just months after it closed its $25 million Series B round. 
Peloton launches second generation bike and cheaper version of treadmill
By Laura Lovett | 01:27 pm | September 08, 2020
Janssen launches new accelerator for digital companies focused on predictive diagnostics and precision treatment
By Laura Lovett | 03:27 pm | September 04, 2020
The EMEA-focused accelerator was an effort between the pharma company, iPEPs and EIT Health.